The presence of prostate-specific antigen checked more than 1 year before diagnostic biopsy is an independent prognostic factor in patients undergoing radical prostatectomy

The presence of prostate-specific antigen checked more than 1 year before diagnostic biopsy is an independent prognostic factor in patients undergoing radical prostatectomy

Purpose: In large scale prospective studies, prostate-specific antigen (PSA)-screening not only decreased prostate cancer mortality, but also reduced biochemical recurrence (BCR) in patients undergoing radical prostatectomy (RP). We investigated the independent effect of the presence of PSA checked...

Full description

Bibliographic Details
Main Authors: Sung Gon Park, Kang Hee Shim, Seol Ho Choo, Se Joong Kim, Sun Il Kim
Format: Article
Language:English
Published: Korean Urological Association 2021-07-01
Series:Investigative and Clinical Urology
Subjects:
cancer screening
prostate cancer
prostate-specific antigen
recurrence
retropubic prostatectomy
Online Access:https://icurology.org/pdf/10.4111/icu.20200545

Internet

https://icurology.org/pdf/10.4111/icu.20200545

Similar Items